NCT04077827View on ClinicalTrials.gov

TIVA Admnistration and Autologous Fat Transfer in Breast Reconstruction

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

March 30, 2020

Study Completion Date

March 30, 2020

Conditions
Breast Cancer
Interventions
DRUG

Propofol

Patients will be divided into 2 groups. The TIVA group (N = 23) will be administrated intravenous anesthesia (propofol-remifentanil), while to the DES group (N = 23) volatile anesthetics (desflurane-remifentanil)

Trial Locations (1)

11522

"Saint Savvas Hospital", Athens

All Listed Sponsors
collaborator

Saint Savvas Anticancer Hospital

OTHER

lead

National and Kapodistrian University of Athens

OTHER

NCT04077827 - TIVA Admnistration and Autologous Fat Transfer in Breast Reconstruction | Biotech Hunter | Biotech Hunter